{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:06:07Z","timestamp":1790665567207,"version":"4.1.0"},"reference-count":16,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title\/>\n                  <jats:p>Mediastinal gray zone lymphoma (MGZL) has immunopathologic features between classical Hodgkin lymphoma (cHL) and primary mediastinal thymic B-cell lymphoma (PMBL), leading to uncertainty regarding its biological relationship to these entities. We performed gene expression profiling from patients with MGZL (20), cHL (18), and PMBL (17) and show MGZL clusters between cHL and PMBL. Expression signatures reveal germinal B-cell and IFN regulatory factor 4 (IRF4) signatures were relatively low in MGZL and cHL compared with PMBL, indicating downregulation of the B-cell program in MGZL, a hallmark of cHL. T-cell and macrophage signatures were higher in MGZL and cHL compared with PMBL, consistent with infiltrating immune cells, which are found in cHL. The NF\u03baB signature was higher in MGZL than PMBL, and like cHL, MGZL and PMBL express NF\u03baB inducing kinase (NIK), indicating noncanonical signaling. These findings indicate that while MGZL has distinctive clustering, it is biologically closer to cHL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Significance:<\/jats:title>\n                  <jats:p>We performed comparative gene expression analysis of MGZL, cHL, and PMBL and show most MGZL cases are biologically closer to cHL. MGZL has significantly higher tumor cell density than cHL and greater NF\u03baB activation compared with PMBL, which may explain its greater treatment resistance compared with cHL and PMBL.<\/jats:p>\n                  <jats:p>This article is highlighted in the In This Issue feature, p. 127<\/jats:p>\n               <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-20-0009","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T18:15:14Z","timestamp":1585592114000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma"],"prefix":"10.1158","volume":"1","author":[{"given":"Stefania","family":"Pittaluga","sequence":"first","affiliation":[{"name":"1Laboratory of Pathology, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Nicolae","sequence":"additional","affiliation":[{"name":"1Laboratory of Pathology, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Wright","sequence":"additional","affiliation":[{"name":"2Biometrics Research Program, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Melani","sequence":"additional","affiliation":[{"name":"3Lymphoid Malignancies Branch, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roschewski","sequence":"additional","affiliation":[{"name":"3Lymphoid Malignancies Branch, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Steinberg","sequence":"additional","affiliation":[{"name":"4Center for Cancer Research, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaWei","family":"Huang","sequence":"additional","affiliation":[{"name":"3Lymphoid Malignancies Branch, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"3Lymphoid Malignancies Branch, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[{"name":"1Laboratory of Pathology, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[{"name":"3Lymphoid Malignancies Branch, NCI, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"2022060217113890500_bib1","volume-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition)","author":"World Health Organisation","year":"2017"},{"key":"2022060217113890500_bib2","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"2022060217113890500_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12308-009-0053-9","article-title":"Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France","volume":"2","author":"Quintanilla-Martinez","year":"2009","journal-title":"J Hematop"},{"key":"2022060217113890500_bib4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1182\/blood-2014-03-564906","article-title":"A prospective study of mediastinal gray-zone lymphoma","volume":"124","author":"Wilson","year":"2014","journal-title":"Blood"},{"key":"2022060217113890500_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.1994.tb04781.x","article-title":"Anaplastic large cell lymphoma (CD30+\/Ki-1+): results of a prospective clinico-pathological study of 69 cases","volume":"86","author":"Pileri","year":"1994","journal-title":"Br J Haematol"},{"key":"2022060217113890500_bib6","first-page":"790","article-title":"Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy","volume":"92","author":"Zinzani","year":"1998","journal-title":"Blood"},{"key":"2022060217113890500_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","article-title":"Gray-zone lymphoma between cHL and large B-cell lymphoma: a histopathologic series from the LYSA","volume":"43","author":"Sarkozy","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"2022060217113890500_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"2022060217113890500_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3324\/haematol.2010.033167","article-title":"Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma","volume":"96","author":"Eberle","year":"2011","journal-title":"Haematologica"},{"key":"2022060217113890500_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2011.116","article-title":"Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations","volume":"24","author":"Eberle","year":"2011","journal-title":"Mod Pathol"},{"key":"2022060217113890500_bib11","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"2022060217113890500_bib12","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1182\/blood-2012-01-405951","article-title":"Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival","volume":"120","author":"Ranuncolo","year":"2012","journal-title":"Blood"},{"key":"2022060217113890500_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.path.2019.03.014","article-title":"Challenges in the diagnosis of gray zone lymphomas","volume":"12","author":"Parker","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"2022060217113890500_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11899-012-0130-5","article-title":"Gray zone lymphoma: better treated like Hodgkin lymphoma or mediastinal large B-cell lymphoma?","volume":"7","author":"Dunleavy","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"2022060217113890500_bib15","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"2022060217113890500_bib16","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/2\/155\/3109361\/155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/1\/2\/155\/3109361\/155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T17:15:47Z","timestamp":1654190147000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/1\/2\/155\/35113\/Gene-Expression-Profiling-of-Mediastinal-Gray-Zone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,30]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-20-0009","relation":{},"ISSN":["2643-3249","2643-3230"],"issn-type":[{"value":"2643-3249","type":"electronic"},{"value":"2643-3230","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,30]]}}}